Abbott Work in process decreased by 5.9% to $904.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.6%, from $840.00M to $904.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 4.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $796.00M | $710.00M | $694.00M | $695.00M | $710.00M | $726.00M | $680.00M | $805.00M | $845.00M | $888.00M | $807.00M | $881.00M | $880.00M | $877.00M | $840.00M | $890.00M | $962.00M | $961.00M | $904.00M |
| QoQ Change | — | -10.8% | -2.3% | +0.1% | +2.2% | +2.3% | -6.3% | +18.4% | +5.0% | +5.1% | -9.1% | +9.2% | -0.1% | -0.3% | -4.2% | +6.0% | +8.1% | -0.1% | -5.9% |
| YoY Change | — | — | — | — | -10.8% | +2.3% | -2.0% | +15.8% | +19.0% | +22.3% | +18.7% | +9.4% | +4.1% | -1.2% | +4.1% | +1.0% | +9.3% | +9.6% | +7.6% |
| % of Inventories | 14.6% | 13.5% | 13.5% | 12.2% | 12.0% | 12.7% | 11.0% | 12.1% | 12.3% | 13.4% | 12.3% | 12.9% | 12.9% | 12.9% | 13.6% | 13.4% | 13.8% | 14.3% | 13.9% |
| Share Change | — | -1.1pp | -0.0pp | -1.2pp | -0.2pp | +0.6pp | -1.6pp | +1.0pp | +0.2pp | +1.1pp | -1.1pp | +0.6pp | +0.0pp | -0.0pp | +0.7pp | -0.2pp | +0.4pp | +0.5pp | -0.4pp |
We use cookies for analytics. See our Privacy and Cookie Policy.